The molecular profile of luminal B breast cancer

References

• CuiXSchiffRArpinoGOsborneCKLeeAVBiology of progesterone receptor loss in breast cancer and its implications for endocrine therapyJ Clin Oncol200523307721773516234531
   PubMed Web of Science ®Google Scholar
• SørlieTPerouCMTibshiraniRGene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProc Natl Acad Sci U S A20019819108691087411553815
   PubMed Web of Science ®Google Scholar
• PerouCMSørlieTEisenMBMolecular portraits of human breast tumoursNature2000406679774775210963602
   PubMed Web of Science ®Google Scholar
• PratAPerouCDeconstructing the molecular portraits of breast cancerMol Oncol20115152321147047
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research NetworkComprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature200845572161061106818772890
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research NetworkIntegrated genomic analyses of ovarian carcinomaNature2011474735360961521720365
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive molecular portraits of human breast tumorsNature2012
   Web of Science ®Google Scholar
• AllredDCBrownPMedinaDThe origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancerBreast Cancer Res20046624024515535853
   PubMed Web of Science ®Google Scholar
• HerschkowitzJISiminKWeigmanVJIdentification of conserved gene expression features between murine mammary carcinoma models and human breast tumorsGenome Biol200785R7617493263
   PubMed Web of Science ®Google Scholar
• CreightonCJLiXLandisMResidual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresProc Natl Acad Sci U S A200910633138201382519666588
   PubMed Web of Science ®Google Scholar
• FarmerPBonnefoiHBecetteVIdentification of molecular apocrine breast tumours by microarray analysisOncogene200524294660467115897907
   PubMed Web of Science ®Google Scholar
• PeppercornJPerouCMCareyLAMolecular subtypes in breast cancer evaluation and management: divide and conquerCancer Invest200826111018181038
   PubMed Web of Science ®Google Scholar
• ParkerJSMullinsMCheangMCSupervised risk predictor of breast cancer based on intrinsic subtypesJ Clin Oncol20092781160116719204204
   PubMed Web of Science ®Google Scholar
• HoadleyKAWeigmanVJFanCEGFR associated expression profiles vary with breast tumor subtypeBMC Genomics2007825817663798
   PubMed Web of Science ®Google Scholar
• PratAEllisMJPerouCMPractical implications of gene-expression-based assays for breast oncologistsNat Rev Clin Oncol201191485722143140
   PubMed Web of Science ®Google Scholar
• NielsenTOParkerJSLeungSA comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancerClin Cancer Res201016215222523220837693
   PubMed Web of Science ®Google Scholar
• ChinKDeVriesSFridlyandJGenomic and transcriptional aberrations linked to breast cancer pathophysiologiesCancer Cell200610652954117157792
   PubMed Web of Science ®Google Scholar
• MillerLDSmedsJGeorgeJAn expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survivalProc Natl Acad Sci U S A200510238135501355516141321
   PubMed Web of Science ®Google Scholar
• DesmedtCPietteFLoiSStrong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation seriesClin Cancer Res200713113207321417545524
   PubMed Web of Science ®Google Scholar
• WangYKlijnJGZhangYGene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerLancet2005365946067167915721472
   PubMed Web of Science ®Google Scholar
• LoiSHaibe-KainsBDesmedtCDefinition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic gradeJ Clin Oncol200725101239124617401012
   PubMed Web of Science ®Google Scholar
• SchmidtMBBöhmDvon TörneCThe humoral immune system has a key prognostic impact in node-negative breast cancerCancer Res200868135405541318593943
   PubMed Web of Science ®Google Scholar
• ZhangYSieuwertsAMMcGreevyMThe 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapyBreast Cancer Res Treat2009116230330918821012
   PubMed Web of Science ®Google Scholar
• MinnAJGuptaGPSiegelPMGenes that mediate breast cancer metastasis to lungNature2005436705051852416049480
   PubMed Web of Science ®Google Scholar
• MinnAJGuptaGPPaduaDLung metastasis genes couple breast tumor size and metastatic spreadProc Natl Acad Sci U S A2007104166740674517420468
   PubMed Web of Science ®Google Scholar
• KesslerJDKahleKTSunTA SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesisScience2012335606634835322157079
   PubMed Web of Science ®Google Scholar
• BaselgaJTreatment of HER2-overexpressing breast cancerAnn Oncol201021Suppl 7vii36vii4020943641
   PubMed Web of Science ®Google Scholar
• OldenhuisCNOostingSFGietemaJAde VriesEGPrognostic versus predictive value of biomarkers in oncologyEur J Cancer200844794695318396036
   PubMed Web of Science ®Google Scholar
• BardouVJArpinoGElledgeRMOsborneCKClarkGMProgesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databasesJ Clin Oncol200321101973197912743151
   PubMed Web of Science ®Google Scholar
• ArpinoGWeissHLeeAVEstrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistanceJ Natl Cancer Inst200597171254126116145046
   PubMedGoogle Scholar
• OsborneCKYochmowitzMGKnightWA3rdMcGuireWLThe value of estrogen and progesterone receptors in the treatment of breast cancerCancer198046Suppl 12288428887448733
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)DaviesCGodwinJRelevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trialsLancet2011378979377178421802721
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative GroupSystemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 womenLancet1992339878571851345869
   PubMed Web of Science ®Google Scholar
• CheangMCChiaSKVoducDKi67 index, HER2 status, and prognosis of patients with luminal B breast cancerJ Natl Cancer Inst20091011073675019436038
   PubMed Web of Science ®Google Scholar
• FanCOhDSWesselsLConcordance among gene-expression-based predictors for breast cancerN Engl J Med2006355656056916899776
   PubMed Web of Science ®Google Scholar
• PaikSShakSTangGA multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancerN Engl J Med2004351272817282615591335
   PubMed Web of Science ®Google Scholar
• van ‘t VeerLJDaiHvan de VijverMJGene expression profiling predicts clinical outcome of breast cancerNature2002415687153053611823860
   PubMed Web of Science ®Google Scholar
• CreightonCJFuXHennessyBTProteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancerBreast Cancer Res2010123R4020569503
   PubMed Web of Science ®Google Scholar
• CreightonCJOsborneCKvan de VijverMJMolecular profiles of progesterone receptor loss in human breast tumorsBreast Cancer Res Treat2009114228729918425577
   PubMed Web of Science ®Google Scholar
• GoldhirschAWoodWCCoatesASStrategies for subtypes – dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Ann Oncol20112281736174721709140
   PubMed Web of Science ®Google Scholar
• OsborneCKSteroid hormone receptors in breast cancer managementBreast Cancer Res Treat199851322723810068081
   PubMed Web of Science ®Google Scholar
• OsborneCKNevenPDirixLYGefitinib or placebo in combination with tamoxifen in patients with hormone receptor-positive metastatic breast cancer: a randomized phase II studyClin Cancer Res20111751147115921220480
   PubMed Web of Science ®Google Scholar
• BaselgaJCamponeMPiccartMEverolimus in postmenopausal hormone-receptor-positive advanced breast cancerN Engl J Med2012366652052922149876
   PubMed Web of Science ®Google Scholar
• CasaAJDearthRKLitzenburgerBCLeeAVCuiXThe type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistanceFront Biosci2008133273328718508432
   PubMed Web of Science ®Google Scholar
• KimHJCuiXHilsenbeckSGLeeAVProgesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancerClin Cancer Res2006123 Pt 21013s1018s16467118
   PubMed Web of Science ®Google Scholar
• ShouJMassarwehSOsborneCKMechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancerJ Natl Cancer Inst2004961292693515199112
   PubMedGoogle Scholar
• TCGA Data Portal [database on the Internet]Bethesda (MD)National Cancer Institutec2007 – [accessed Nov 2010]. Available from: http://tcga-data.nci.nih.gov/tcga/.
   Google Scholar
• CreightonCJMassarwehSHuangSDevelopment of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenograftsCancer Res200868187493750118794137
   PubMed Web of Science ®Google Scholar
• MillerTWHennessyBTGonzález-AnguloAMHyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancerJ Clin Invest201012072406241320530877
   PubMed Web of Science ®Google Scholar
• BaylissJHilgerAVishnuPDiehlKEl-AshryDReversal of the estrogen receptor negative phenotype in breast cancer and restoration of antiestrogen responseClin Cancer Res200713237029703618056179
   PubMed Web of Science ®Google Scholar
• WeigeltBHuZHeXMolecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancerCancer Res200565209155915816230372
   PubMed Web of Science ®Google Scholar
• Abdel-FatahTMPoweDGHodiZReis-FilhoJSLeeAHEllisIOMorphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia familyAm J Surg Pathol200832451352318223478
   PubMed Web of Science ®Google Scholar